Press Releases

Features company's patented SimpliSqueeze® valve for ready-to-dispense convenience, focused on reducing mess and drips AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced it has launched a new line of inverted lidless dispensing closures for the beauty and personal care markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427887104/en/Aptar's Inverted Lidless Dispensing Closures Aptar's inverted lidless closures help eliminate the need for separate lids while allowing for an inverted, ready-to-dispense packaging format that he

DAYTONA BEACH, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) (the "Company") announced its unaudited financial results for the first quarter of 2026. For the first quarter ended March 31, 2026, the Company achieved: Total revenues of $1.9 billion, increasing $497 million, or 35.4%, compared to the first quarter of the prior year, with flat Organic Revenue and Organic Revenue with Contingents increasing 2.2%.Income before income taxes of $533 million, increasing 24.8%, with Income Before Income Taxes Margin of 28.0%, compared to 30.4% in the first quarter of the prior year.EBITDAC - Adjusted of $731 million, increasing 36.6%, with EBITDAC Margin - Adjusted of 38.

Airline also introduces up to $250,000 'We Serve Together' grant for Employees and nonprofits they serveDALLAS, April 27, 2026 /PRNewswire/ -- Southwest Airlines Co. (NYSE:LUV) celebrates the 250th anniversary of the nation's founding with the introduction of Independence One, a special new livery from the airline that is known for democratizing the skies. Independence One will join two additional Southwest® America-themed planes—Freedom One, which has been in the fleet since 2021, and Liberty One, a second newly-introduced aircraft painted in an American flag theme. "With our new Independence One and Liberty One aircraft, we honor this important milestone in our

HCA Healthcare (NYSE:HCA) today announced that Cynthia Cifuentes-Finkel has been named senior vice president of marketing and corporate affairs, effective June 8, 2026. She will report to Mike McAlevey, executive vice president, chief legal and administrative officer, and will lead enterprise marketing, corporate communications, and stakeholder engagement in support of HCA Healthcare's enterprise growth priorities. "Cynthia is a strategic and accomplished leader with deep experience building trusted brands, strengthening reputation and aligning communications with organizational strategic imperatives," said McAlevey. "She brings a strong track record of leading high-performing teams, navi

Archer Aviation Inc. (NYSE:ACHR) will report its first quarter 2026 operating update and financial results after market close on Monday, May 11, 2026. The company will host a live webcast to discuss its results at 2:00 p.m. Pacific Time. The live webcast and replay will be available at investors.archer.com.To listen to the conference call, dial 1 833-461-5787 (domestic) or +1 585-542-9983 (international) and enter the access code 641143600. Archer will also utilize Say Technologies' Q&A Platform to allow shareholders to submit and vote on questions by visiting https://app.saytechnologies.com/archer-aviation-2026-q1. About Archer Archer is designing and developing the technologies an

ACHESON, Alberta, April 27, 2026 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. ("NACG" or "the Company") (TSX:NOA, NYSE:NOA) announced today that it will release its financial results for the first quarter ended March 31, 2026 on Wednesday, May 13, 2026 after markets close. Following the release of its financial results, NACG will hold a conference call and webcast on Thursday, May 14, 2026, at 7:00 a.m. Mountain Time (9:00 a.m. Eastern Time). The call can be accessed by dialing:Toll free: 1-800-717-1738Conference ID:96416 A replay will be available through June 12, 2026, by dialing:Toll Free: 1-888-660-6264Conference ID: 96416Playback Passcode: 96416 A slide deck for the w

PHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (NASDAQ:CABA), a late-stage clinical biotechnology company focused on developing and launching targeted cell therapies designed specifically for patients with autoimmune diseases, today announced multiple upcoming presentations including manufacturing, translational and clinical data on rese-cel (resecabtagene autoleucel) at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting, being held from May 11-15, 2026, in Boston, MA. The presentations will feature clinical and translational data from the lowest dose cohort of rese-cel without preconditioning in RESET-PV® (pemphigus vulgaris), and initial transl

BOULDER, Colo., April 27, 2026 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), a technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced the closing of its previously announced best efforts public offering of an aggregate of 5,084,743 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 5,084,743 shares of common stock (the "Warrants"), at a combined public offering price of $2.36 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants have an exerci

Tidewater Inc. (NYSE:TDW) ("Tidewater" or the "Company") announced today that it will release financial results for the three months ending March 31, 2026, on Monday, May 4, 2026 after market close. An earnings conference call has been scheduled for Tuesday, May 5, 2026, at 8:00 a.m. Central Time, during which President and Chief Executive Officer Quintin Kneen will discuss results for the three months ending March 31, 2026. Investors and interested parties may listen to the earnings conference call via telephone by calling +1.800.715.9871 if calling from the U.S. or Canada (+1.647.932.3411 if calling from outside the U.S.) and provide Conference ID: 8745688 prior to the scheduled start t

WAYNE, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide the full results from its Phase 1a single and multiple ascending dose trial of its anti-TSLP/IL-4R bispecific antibody ATI-052 and the results of its lead indication selection process for its ITK/JAK3 Inhibitor ATI-2138 before the opening of the financial markets tomorrow, April 28, 2026. Aclaris will host a webcast and conference call with slides tomorrow morning at 8:30 AM EST to discuss these updates. The live and archived webcast will be a

First Quarter 2026 Highlights: Net interest margin of 4.25% Loan growth of 16.2%, annualized 24.7% noninterest income to total revenue1 Net income of $21.6 million, $0.76 per diluted share (adjusted, $23.7 million, $0.84 per diluted share, see "Non-GAAP Financial Measures and Reconciliations" below) Return on average total assets of 1.04% (adjusted, 1.14%, see "Non-GAAP Financial Measures and Reconciliations" below) Return on average stockholders' equity of 7.47% (adjusted, 8.20%, see "Non-GAAP Financial Measures and Reconciliations" below) FirstSun Capital Bancorp ("FirstSun") (NASDAQ:FSUN) reported net income of $21.6 million for the first quarter of 2026 compared to

CHARLESTON, W.Va., April 27, 2026 /PRNewswire/ -- West Virginia American Water is pleased to announce a $500,000 infrastructure upgrade project on 17th Street in Dunbar."We are committed to continued investment in our infrastructure systems across the state," said Scott Wyman, President of West Virginia American Water. "This project will benefit the Dunbar community and customers we serve and allow us to continue providing safe, clean, reliable and affordable water."The project entails replacing 800 feet of aging pipe with 6-inch and 2-inch PVC main and will occur on 17th Street between Fletcher Avenue and Route 25 – Fairlawn Avenue. It is scheduled to be completed by the end of May, and the

HAMILTON, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) ("the Bank") today announced results for the first quarter of 2026. Net income for the first quarter of 2026 was $7.6 million, or $0.30 per diluted share, compared to $9.4 million, or $0.37 per diluted share, for the first quarter of 2025. Return on average assets, return on average equity and return on average tangible equityi for the first quarter of 2026 were 0.79%, 6.89% and 7.78%, respectively, compared to 1.00%, 9.20% and 10.54%, respectively, for the first quarter of 2025. First Quarter 2026 Performance Highlights:  ●Total loans were $3.30 billion at March 31, 2026, increasing $68.1 million,

Central Garden & Pet Company (NASDAQ:CENT) (NASDAQ:CENTA) ("Central"), a leading consumer goods company in the pet and garden industries, will release its fiscal 2026 second quarter results for the period ending March 28, 2026, after market close on Wednesday, May 6, 2026. On the same day, Central will host a conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time), led by CEO Niko Lahanas and CFO Brad Smith, to review these results and to provide a business update. A live webcast, replay and related materials will be available at http://ir.central.com. To join by phone, please dial +1 (201) 689-8345 for both domestic and international participants. About Central Garden & Pet

PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership

Onterris, Inc. (NYSE:MONTROSE, Inc., MEG, NYSE:ONTERRIS, Inc., ONT on May 4, 2026)), a global environmental solutions company solving complex challenges for planet and progress, today announced the planned dates for its first quarter fiscal year 2026 results and conference call. On Wednesday, May 6, 2026, after the close of trading on the New York Stock Exchange, Onterris intends to release its first quarter fiscal year 2026 results. On Thursday, May 7, 2026, at 8:30 a.m. Eastern Time, Onterris plans to host a conference call to discuss these results and the forward outlook. A live webcast of the conference call will be available in the Investors section of the Onterris website at ir.

- Data underscore the differentiated capability of the clinically validated FORCE platform to cross the blood-brain barrier - WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it will present new preclinical data demonstrating the ability of the FORCE platform to cross the blood-brain barrier (BBB) and enable robust knockdown of MAPT RNA in the central nervous system (CNS) at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting being held May 11-15, 2026, in Boston, MA, and vir

Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the "Company") will host a conference call and webcast on Monday, May 11, 2026 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's first quarter 2026 results. The Company expects to issue a news release detailing the results prior to the May 11 conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 461-5787; the dial-in number for participants in Canada is (365) 657-4084; the dial-in number for pa

Johnson & Johnson (NYSE:JNJ) will present at the Bernstein's 42nd Annual Strategic Decisions Conference on Wednesday, May 27th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available approximately 48 hours after the webcast. View source version on businesswire.com: https://www.businesswire.com/news/home/20260427510768/en/ Media contact: media-relations@its.jnj.com Investor contact: investor-relations@its.jnj.c

PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the planned retirement of Mark Hancock — PACS co-founder, first CFO, and one of the principal architects behind the company's success — on June 30, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427554117/en/Mark Hancock, PACS Group co-founder and retiring Chief Financial Officer Mr. Hancock co-founded PACS in 2013 alongside Jason Murray, PACS's Chairman and CEO, with just two post-acute care facilities in San Diego, CA. Under his leadership as CFO, PACS expanded from those two facilities to 323